{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:36:55Z","timestamp":1758127015216,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K09152"],"award-info":[{"award-number":["JP18K09152"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00210-020-01921-2","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T17:03:37Z","timestamp":1592499817000},"page":"2073-2080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Additive effects of intravenous and intravesical application of vibegron, a \u03b23-adrenoceptor agonist, on bladder function in rats with bladder overactivity"],"prefix":"10.1007","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7426-6395","authenticated-orcid":false,"given":"Akira","family":"Furuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"1921_CR1","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1523\/JNEUROSCI.22-18-08063.2002","volume":"22","author":"LA Birder","year":"2002","unstructured":"Birder LA, Nealen ML, Kiss S, de Groat WC, Caterina MJ, Wang E, Apodaca G, Kanai AJ (2002) Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 22:8063\u20138070","journal-title":"J Neurosci"},{"key":"1921_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/nau.23224","volume":"36","author":"A Coelho","year":"2017","unstructured":"Coelho A, Antunes-Lopes T, Gillespie J, Cruz F (2017) Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: an immunohistochemical study. Neurourol Urodyn 36:1972\u20131980. https:\/\/doi.org\/10.1002\/nau.23224","journal-title":"Neurourol Urodyn"},{"key":"1921_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2015.03.074","volume":"758","author":"G D\u2019 Agostino","year":"2015","unstructured":"D\u2019 Agostino G, Maria Condino A, Calvi P (2015) Involvement of beta3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: direct evidence by [(3)H]-acetylcholine release experiments in the isolated detrusor. Eur J Pharmacol 758:115\u2013122. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.074","journal-title":"Eur J Pharmacol"},{"key":"1921_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1021\/acs.jmedchem.5b01372","volume":"59","author":"SD Edmondson","year":"2016","unstructured":"Edmondson SD, Zhu C, Kar NF, di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE (2016) Discovery of vibegron: a potent and selective beta3 adrenergic receptor agonist for the treatment of overactive bladder. J Med Chem 59:609\u2013623. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01372","journal-title":"J Med Chem"},{"key":"1921_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/iju.13066","volume":"23","author":"A Furuta","year":"2016","unstructured":"Furuta A, Suzuki Y, Kimura S, Koike Y, Egawa S, Yoshimura N (2016) Combination therapy with beta3 -adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: efficacy in rats with bladder overactivity. Int J Urol 23:425\u2013430. https:\/\/doi.org\/10.1111\/iju.13066","journal-title":"Int J Urol"},{"key":"1921_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00210-012-0824-1","volume":"386","author":"Y Igawa","year":"2013","unstructured":"Igawa Y, Michel MC (2013) Pharmacological profile of beta3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome. Naunyn Schmiedeberg's Arch Pharmacol 386:177\u2013183. https:\/\/doi.org\/10.1007\/s00210-012-0824-1","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1921_CR7","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1111\/bph.14658","volume":"176","author":"Y Igawa","year":"2019","unstructured":"Igawa Y, Aizawa N, Michel MC (2019) beta3 -Adrenoceptors in the normal and diseased urinary bladder-what are the open questions? Br J Pharmacol 176:2525\u20132538. https:\/\/doi.org\/10.1111\/bph.14658","journal-title":"Br J Pharmacol"},{"key":"1921_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1124\/jpet.116.236497","volume":"360","author":"Y Ito","year":"2017","unstructured":"Ito Y, Kuraoka S, Endo S, Takahashi A, Onoue S, Yamada S (2017) Urinary excretion contributes to long-lasting blockade of bladder muscarinic receptors by Imidafenacin: effect of bilateral ureteral ligation. J Pharmacol Exp Ther 360:69\u201374. https:\/\/doi.org\/10.1124\/jpet.116.236497","journal-title":"J Pharmacol Exp Ther"},{"key":"1921_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/nau.20965","volume":"30","author":"FA Kullmann","year":"2011","unstructured":"Kullmann FA, Downs TR, Artim DE, Limberg BJ, Shah M, Contract D, de Groat WC, Rosenbaum JS (2011) Urothelial beta-3 adrenergic receptors in the rat bladder. Neurourol Urodyn 30:144\u2013150. https:\/\/doi.org\/10.1002\/nau.20965","journal-title":"Neurourol Urodyn"},{"key":"1921_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00441-010-1053-x","volume":"342","author":"BJ Limberg","year":"2010","unstructured":"Limberg BJ, Andersson KE, Aura Kullmann F, Burmer G, de Groat WC, Rosenbaum JS (2010) Beta-adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res 342:295\u2013306. https:\/\/doi.org\/10.1007\/s00441-010-1053-x","journal-title":"Cell Tissue Res"},{"key":"1921_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.urology.2009.12.013","volume":"75","author":"Y Matsumoto","year":"2010","unstructured":"Matsumoto Y, Miyazato M, Furuta A, Torimoto K, Hirao Y, Chancellor MB, Yoshimura N (2010) Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology 75:862\u2013867. https:\/\/doi.org\/10.1016\/j.urology.2009.12.013","journal-title":"Urology"},{"key":"1921_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.ju.0000067621.62736.7c","volume":"170","author":"M Nomiya","year":"2003","unstructured":"Nomiya M, Yamaguchi O (2003) A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649\u2013653. https:\/\/doi.org\/10.1097\/01.ju.0000067621.62736.7c","journal-title":"J Urol"},{"key":"1921_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00210-018-1510-8","volume":"391","author":"D Sellers","year":"2018","unstructured":"Sellers D, Chess-Williams R, Michel MC (2018) Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium. Naunyn Schmiedeberg's Arch Pharmacol 391:675\u2013694. https:\/\/doi.org\/10.1007\/s00210-018-1510-8","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1921_CR14","doi-asserted-by":"publisher","first-page":"F388","DOI":"10.1152\/ajprenal.00392.2016","volume":"313","author":"I Silva","year":"2017","unstructured":"Silva I, Costa AF, Moreira S, Ferreirinha F, Magalh\u00e3es-Cardoso MT, Calejo I, Silva-Ramos M, Correia-de-S\u00e1 P (2017) Inhibition of cholinergic neurotransmission by beta3-adrenoceptors depends on adenosine release and A1-receptor activation in human and rat urinary bladders. Am J Physiol Renal Physiol 313:F388\u2013F403. https:\/\/doi.org\/10.1152\/ajprenal.00392.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"1921_CR15","doi-asserted-by":"publisher","first-page":"C254","DOI":"10.1152\/ajpcell.00025.2006","volume":"291","author":"W Yu","year":"2006","unstructured":"Yu W, Zacharia LC, Jackson EK, Apodaca G (2006) Adenosine receptor expression and function in bladder uroepithelium. Am J Physiol Cell Physiol 291:C254\u2013C265. https:\/\/doi.org\/10.1152\/ajpcell.00025.2006","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01921-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-020-01921-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01921-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:10:56Z","timestamp":1623971456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-020-01921-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01921-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"27 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}